Artikler med mandater om offentlig tilgang - Gert StormLes mer
Ikke tilgjengelige noe sted: 11
Gå gjennom
Intrinsically active nanobody-modified polymeric micelles for tumor-targeted combination therapy
M Talelli, S Oliveira, CJF Rijcken, EHE Pieters, T Etrych, K Ulbrich, ...
Biomaterials 34 (4), 1255-1260, 2013
Mandater: German Research Foundation
Gå gjennom
Low-toxicity transferrin-guided polymersomal doxorubicin for potent chemotherapy of orthotopic hepatocellular carcinoma in vivo
Y Wei, X Gu, L Cheng, F Meng, G Storm, Z Zhong
Acta biomaterialia 92, 196-204, 2019
Mandater: National Natural Science Foundation of China
Gå gjennom
Examining the role of Rac1 in tumor angiogenesis and growth: a clinically relevant RNAi-mediated approach
P Vader, R Van Der Meel, MH Symons, M Fens, E Pieters, KJ Wilschut, ...
Angiogenesis 14, 457-466, 2011
Mandater: Science Foundation Ireland
Gå gjennom
Superoxide Dismutase Enzymosomes: Carrier Capacity Optimization, in Vivo Behaviour and Therapeutic Activity
ML Corvo, HS Marinho, P Marcelino, RM Lopes, CA Vale, CR Marques, ...
Pharmaceutical research 32, 91-102, 2015
Mandater: Fundação para a Ciência e a Tecnologia, Portugal
Gå gjennom
Hyperthermia-triggered release of hypoxic cell radiosensitizers from temperature-sensitive liposomes improves radiotherapy efficacy in vitro
N Sadeghi, RJ Kok, C Bos, M Zandvliet, WJC Geerts, G Storm, ...
Nanotechnology 30 (26), 264001, 2019
Mandater: European Commission
Gå gjennom
Injectable liposomal docosahexaenoic acid alleviates atherosclerosis progression and enhances plaque stability
SY Chong, X Wang, L van Bloois, C Huang, NS Syeda, S Zhang, HJ Ting, ...
Journal of Controlled Release 360, 344-364, 2023
Mandater: National Medical Research Council, Singapore
Gå gjennom
Fluorescently labeled microbubbles for facilitating translational molecular ultrasound studies
P Koczera, Z Wu, S Fokong, B Theek, L Appold, S Jorge, D Möckel, Z Liu, ...
Drug delivery and translational research 2, 56-64, 2012
Mandater: German Research Foundation
Gå gjennom
Preclinical evaluation of thermosensitive poly (N-(2-hydroxypropyl) methacrylamide mono/dilactate)-grafted liposomes for cancer thermochemotherapy
M van Elk, JB van den Dikkenberg, G Storm, WE Hennink, T Vermonden, ...
International journal of pharmaceutics 550 (1-2), 190-199, 2018
Mandater: Dutch Cancer Society
Gå gjennom
CCL2 chemokine inhibition primes the tumor vasculature for improved nanomedicine delivery and efficacy
D Möckel, M Bartneck, P Niemietz, M Wagner, J Ehling, E Rama, M Weiler, ...
Journal of Controlled Release 365, 358-368, 2024
Mandater: German Research Foundation, European Commission
Gå gjennom
Liposomal drug delivery system for anti-inflammatory treatment after cataract surgery: A phase I/II clinical trial
CW Wong, E Wong, JM Metselaar, G Storm, TT Wong
Drug Delivery and Translational Research, 1-8, 2022
Mandater: National Medical Research Council, Singapore, National Health Innovation …
Gå gjennom
Neutrophil Hitchhiking Enhances Liposomal Dexamethasone Therapy of Sepsis
R Mathur, S Elsafy, AT Press, J Brück, M Hornef, L Martin, T Schürholz, ...
ACS nano 18 (42), 28866-28880, 2024
Mandater: European Commission
Tilgjengelige et eller annet sted: 153
Gå gjennom
Drug targeting to tumors: principles, pitfalls and (pre-) clinical progress
T Lammers, F Kiessling, WE Hennink, G Storm
Journal of controlled release 161 (2), 175-187, 2012
Mandater: German Research Foundation
Gå gjennom
Challenges and strategies in anti-cancer nanomedicine development: An industry perspective
JI Hare, T Lammers, MB Ashford, S Puri, G Storm, ST Barry
Advanced drug delivery reviews 108, 25-38, 2017
Mandater: European Commission
Gå gjennom
Noninvasive imaging of nanomedicines and nanotheranostics: principles, progress, and prospects
S Kunjachan, J Ehling, G Storm, F Kiessling, T Lammers
Chemical reviews 115 (19), 10907-10937, 2015
Mandater: German Research Foundation, European Commission
Gå gjennom
Recent progress in nanomedicine: therapeutic, diagnostic and theranostic applications
LY Rizzo, B Theek, G Storm, F Kiessling, T Lammers
Current opinion in biotechnology 24 (6), 1159-1166, 2013
Mandater: German Research Foundation, European Commission
Gå gjennom
The battle of “nano” paclitaxel
AM Sofias, M Dunne, G Storm, C Allen
Advanced drug delivery reviews 122, 20-30, 2017
Mandater: Canadian Institutes of Health Research, Natural Sciences and Engineering …
Gå gjennom
Passive versus active tumor targeting using RGD-and NGR-modified polymeric nanomedicines
S Kunjachan, R Pola, F Gremse, B Theek, J Ehling, D Moeckel, ...
Nano letters 14 (2), 972-981, 2014
Mandater: German Research Foundation, European Commission
Gå gjennom
Multidrug resistance: Physiological principles and nanomedical solutions
S Kunjachan, B Rychlik, G Storm, F Kiessling, T Lammers
Advanced drug delivery reviews 65 (13-14), 1852-1865, 2013
Mandater: German Research Foundation
Gå gjennom
Cancer nanomedicine: is targeting our target?
T Lammers, F Kiessling, M Ashford, W Hennink, D Crommelin, G Storm
Nature Reviews Materials 1 (9), 1-2, 2016
Mandater: German Research Foundation, European Commission
Gå gjennom
Pharmacological and physical vessel modulation strategies to improve EPR-mediated drug targeting to tumors
T Ojha, V Pathak, Y Shi, WE Hennink, CTW Moonen, G Storm, F Kiessling, ...
Advanced drug delivery reviews 119, 44-60, 2017
Mandater: German Research Foundation, European Commission
Informasjon om publisering og finansiering fastsettes automatisk av et datamaskinprogram